112 related articles for article (PubMed ID: 9430094)
1. [Repeated dose toxicity studies of taltirelin tetrahydrate (TA-0910) with oral administration to dogs].
Inui T; Yuasa H; Adachi T; Kawai Y; Kudow S
J Toxicol Sci; 1997 Nov; 22 Suppl 2():357-69. PubMed ID: 9430094
[TBL] [Abstract][Full Text] [Related]
2. [Repeated dose toxicity studies of taltirelin tetrahydrate(TA-0910) by oral administration to rats].
Inui T; Fujiwara T; Susami M; Hishida N; Kuwamura Y; Kuse H; Kawai Y; Kudow S
J Toxicol Sci; 1997 Nov; 22 Suppl 2():335-56. PubMed ID: 9430093
[TBL] [Abstract][Full Text] [Related]
3. [Acute toxicity studies of taltirelin tetrahydrate in mice, rats, and dogs].
Hishida N; Kuse H; Yamamura T; Noguchi M; Kawai Y; Hori M
J Toxicol Sci; 1997 Nov; 22 Suppl 2():327-34. PubMed ID: 9430092
[TBL] [Abstract][Full Text] [Related]
4. Oncogenicity studies of taltirelin tetrahydrate (TA-0910) by oral (GAVAGE) administration in CD-1 mice and CD rats.
Yamamura T; Nishimura T; Kuwamura Y; Inui T; Aughton P; Kawai Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():419-30. PubMed ID: 9430099
[TBL] [Abstract][Full Text] [Related]
5. [Reproductive and developmental toxicity studies of taltirelin hydrate (2) teratogenicity study in rats by oral administration].
Imahie H; Kobayashi T; Nishida A; Imado N; Asano Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():381-94. PubMed ID: 9430096
[TBL] [Abstract][Full Text] [Related]
6. [Reproductive and developmental toxicity studies of taltirelin hydrate (1) fertility study in rats by oral administration].
Imahie H; Kobayashi T; Imado N; Inui T; Ariyuki F; Asano Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():371-9. PubMed ID: 9430095
[TBL] [Abstract][Full Text] [Related]
7. [Reproductive and developmental toxicity studies of taltirelin hydrate (3) teratogenicity study in rabbits by oral administration].
Imahie H; Nishida A; Imado N; Asano Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():395-403. PubMed ID: 9430097
[TBL] [Abstract][Full Text] [Related]
8. [Reproductive and developmental toxicity studies of taltirelin hydrate (4) perinatal and postnatal study in rats by oral administration].
Imahie H; Koguchi A; Kobayashi T; Asano Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():405-17. PubMed ID: 9430098
[TBL] [Abstract][Full Text] [Related]
9. [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 9-week recovery test].
Ishibashi S; Nishizawa Y; Taniguchi Y; Kikumori M; Nishimori T; Iwakura K; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():237-57. PubMed ID: 9019560
[TBL] [Abstract][Full Text] [Related]
10. [Single dose toxicity studies of montirelin hydrate(NS-3) in mice, rats and dogs].
Kikumori M; Nishida I; Nishimura T; Yasuhira K; Nakai N; Nishiguchi Y; Iwakura K; Nagasawa H; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():153-63. PubMed ID: 9019555
[TBL] [Abstract][Full Text] [Related]
11. [Single and 4-week oral toxicity studies of prulifloxacin (NM441) in aged dogs].
Ihara T; Akune A; Nakama K; Chihaya Y; Nagata R; Sumi N; Asaoka H; Shindo Y
J Toxicol Sci; 1996 Jun; 21 Suppl 1():149-69. PubMed ID: 8709158
[TBL] [Abstract][Full Text] [Related]
12. [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 9-week recovery test].
Furukawa S; Nishida I; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():191-213. PubMed ID: 9019558
[TBL] [Abstract][Full Text] [Related]
13. [Four-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 4-week recovery test].
Harling RJ; Gopinath C; Matthiesen T; Ishibashi S; Iwakura K; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():215-36. PubMed ID: 9019559
[TBL] [Abstract][Full Text] [Related]
14. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Han J; Shin HC; Kim JC; Kim B
Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
[TBL] [Abstract][Full Text] [Related]
15. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
Yamamura M; Suzuki M; Matsumoto K
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
[TBL] [Abstract][Full Text] [Related]
17. Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, TA-0910, of the pituitary-thyroid axis in subjects with brain stroke.
Miyashita K; Murakami M; Satoh T; Monden T; Yamada M; Iriuchijima T; Kazihara A; Mori M
Intern Med; 1993 Sep; 32(9):681-5. PubMed ID: 8142670
[TBL] [Abstract][Full Text] [Related]
18. [Five-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 4-week recovery test].
Kikumori M; Nishida I; Kojima M; Taniguchi Y; Yasuhira K; Ishibashi S; Iwakura K; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():171-89. PubMed ID: 9019557
[TBL] [Abstract][Full Text] [Related]
19. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
Kinoshita K; Fukushima T; Kodama Y; Sugihara J; Yamamura M; Matsuoka Y
Biol Pharm Bull; 1997 Jan; 20(1):36-9. PubMed ID: 9013803
[TBL] [Abstract][Full Text] [Related]
20. Ethylbenzene: 4- and 13-week rat oral toxicity.
Mellert W; Deckardt K; Kaufmann W; van Ravenzwaay B
Arch Toxicol; 2007 May; 81(5):361-70. PubMed ID: 17058104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
